Inventor · disambiguated record
Anthony Gagliardi
Also filed as: GAGLIARDI ANTHONY
7 granted patents·6 pending applications·24 citations·filing 2015–2024
82Inventor score
Top patents by PatentIndex Score
13 records- 0191US10457960B2Methods and compositions for targeted genetic modification using paired guide RNAsREGENERON PHARMA·Filed 2015·Granted Oct 29, 2019·5 cites·53 claims
- 0291US10106820B2Methods and compositions for modifying a targeted locusREGENERON PHARMA·Filed 2015·Granted Oct 23, 2018·6 cites·43 claims
- 0391US9902971B2Methods for producing a mouse XY embryonic (ES) cell line capable of producing a fertile XY female mouse in an F0 generationREGENERON PHARMA·Filed 2015·Granted Feb 27, 2018·5 cites·41 claims
- 0490US10793874B2Methods and compositions for targeted genetic modifications and methods of useREGENERON PHARMA·Filed 2018·Granted Oct 6, 2020·4 cites·13 claims
- 0586US2024352489A1Methods and compositions for modifying a targeted locusREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0685US10294494B2Methods and compositions for modifying a targeted locusREGENERON PHARMA·Filed 2017·Granted May 21, 2019·2 cites·43 claims
- 0782US12060571B2Methods and compositions for modifying a targeted locusREGENERON PHARMA·Filed 2019·Granted Aug 13, 2024·1 cites·49 claims
- 0880US2023332185A1Methods and compositions for targeted genetic modification using paired guide rnasREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0979US11697828B2Methods and compositions for targeted genetic modification using paired guide RNAsREGENERON PHARMA·Filed 2019·Granted Jul 11, 2023·1 cites·33 claims
- 1070US2021024953A1Methods and compositions for targeted genetic modifications and methods of useREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 1163US2016060657A1Methods and compositions for the targeted modification of a genomeREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1259US2023114649A1HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1358US2016046960A1Methods and compositions for targeted genetic modifications and methods of useREGENERON PHARMA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anthony Gagliardi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →